lapaʻau maʻi ʻaʻai maʻi maʻi ʻōpū liʻiliʻi

ʻO ka maʻi maʻi maʻi pūpū liʻiliʻi liʻiliʻi (ES-SCLC) ke hōʻike nei i nā pilikia kūʻokoʻa. Hoʻopili maʻamau ka lāʻau lapaʻau i ka hui ʻana o ka chemotherapy a me ka immunotherapy, pinepine pū me ka radiation therapy e mālama i nā hōʻailona. Ke hoʻomau nei ka noiʻi ʻana i nā lāʻau lapaʻau hou a me nā hoʻolālā e hoʻomaikaʻi i nā hopena a me ka maikaʻi o ke ola no nā poʻe maʻi me ES-SCLC. Understanding Extensive Stage Small Cell Lung CancerKa ma'i 'a'ai māmā li'ili'i ka pae nui (ES-SCLC) ʻike ʻia i ka wā i laha ʻia ai ka maʻi kanesa ma mua o hoʻokahi māmā a me nā ʻōpū lymph kokoke. ʻO ia hoʻi, ua metastasized ʻo ia i nā wahi ʻē aʻe o ke kino, e like me ka māmā ʻē aʻe, nā nodes lymph mamao, iwi, ate, a i ʻole lolo. 'O ka ma'i 'a'ai māmā li'ili'i (SCLC) he 'ano ko'iko'i o ka ma'i 'a'ai māmā e ulu a laha wikiwiki. Ma ka pae nui, e kau ana ka lapaau i ka hoomalu ana i ka ma'i kanesa a me ka hooikaika ana i ka maikai o ke ola. lapaʻau maʻi ʻaʻai maʻi maʻi ʻōpū liʻiliʻi hoʻolālā. Hiki i nā kaʻina hana diagnostic ke komo: Ka hoʻokolohua kino a me ka mōʻaukala olakino Nā hoʻāʻo kiʻi: X-ray o ka umauma, CT scans, PET scans, MRI Biopsy: No ka hōʻoia ʻana i ka loaʻa ʻana o ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi o ka ʻōpū o ka iwi: E nānā i ka laha ʻana o ka maʻi maʻi i ka iwi iwi. pae nui liʻiliʻi maʻi ʻaʻai māmā e komo pū me ka chemotherapy, immunotherapy, a me ka radiation therapy. Hoʻohana pinepine ʻia kēia mau lāʻau lapaʻau i ka hui ʻana no ka loaʻa ʻana o ka hopena maikaʻi loa. Pili ia i ka hoʻohana ʻana i nā lāʻau lapaʻau e pepehi i nā maʻi maʻi maʻi a puni ke kino. ʻO nā papa lāʻau lapaʻau maʻamau: Etoposide a me nā lāʻau platinum-based (cisplatin a i ʻole carboplatin) Irinotecan a me nā lāʻau lapaʻau platinum Hoʻomaʻamaʻa pinepine ʻia ka Chemotherapy i nā pōʻai, me nā manawa lapaʻau e ukali ʻia e nā manawa hoʻomaha e hiki ai i ke kino ke ola. Hiki i nā hopena ʻaoʻao o ka chemotherapy ke komo i ka nausea, ka luaʻi, ka luhi, ka lauoho lauoho, a me ka nui o ka pilikia o ka maʻi.Immunotherapy ʻO ka Immunotherapy kahi ala lapaʻau hou e kōkua i ke kino o ke kino e hakakā i ka maʻi kanesa. Hoʻohana pinepine ʻia nā mea hoʻopaʻapaʻa pale pale, e like me atezolizumab a me durvalumab, i hui pū ʻia me ka chemotherapy lapaʻau maʻi ʻaʻai maʻi maʻi ʻōpū liʻiliʻi. Hoʻohana kēia mau lāʻau lapaʻau ma ke kāohi ʻana i nā protein ma nā pūnaewele maʻi maʻi a i ʻole nā ​​​​pūnaewele immune e pale ai i ka ʻōnaehana pale mai ka hoʻouka ʻana i ka maʻi kanesa. ʻO Atezolizumab me ka carboplatin a me ka etoposide no ka lāʻau lapaʻau mua o ka maʻi kanesa liʻiliʻi liʻiliʻi liʻiliʻi (ES-SCLC) i hoʻomaikaʻi i ke ola holoʻokoʻa (OS) i hoʻohālikelike ʻia me ka chemotherapy wale nō. Ma IMpower133, ʻo ka OS median he 12.3 mau mahina me atezolizumab / chemotherapy me 10.3 mau mahina me ka chemotherapy (HR, 0.70; 95% CI, 0.54-0.91; P = 0.0069)Puna: Pūnaehana CancerHoʻohana ʻia ka Radiation Therapy Hoʻohana ka lāʻau lapaʻau i nā kukuna ikehu kiʻekiʻe e pepehi i nā maʻi maʻi maʻi. Hiki ke hoʻohana ʻia e: E mālama i nā maʻi koko i loko o ka māmā a i ʻole nā ​​wahi ʻē aʻe o ke kino E hoʻomaha i nā hōʻailona e like me ka ʻeha a i ʻole ka paʻakikī o ka hanu Kāohi a mālama ʻana paha i nā metastases lolo Hiki ke ʻōlelo ʻia ka prophylactic cranial irradiation (PCI) e pale i ka laha ʻana o ka maʻi kanesa i ka lolo. Hiki i nā hopena ʻaoʻao o ka lāʻau lapaʻau ke komo i ka luhi, ka ʻili o ka ʻili, a me ka paʻakikī o ka ʻai ʻana. ʻO nā maʻi me pae nui liʻiliʻi maʻi ʻaʻai māmā hiki ke kūpono ke komo i nā hoʻokolohua lapaʻau e loiloi ana i nā lāʻau lapaʻau hou, nā hui pū ʻana o nā lāʻau lapaʻau, a i ʻole nā ala ʻē aʻe. Hiki ke hāʻawi ʻia me nā lāʻau lapaʻau ʻē aʻe a hiki ke kōkua i ka mālama ʻana i ka ʻeha, luhi, pōkole o ka hanu, a me nā hōʻailona ʻē aʻe e pili ana me ES-SCLC. ʻO ka hui loea ma Shandong Baofa Cancer Research Institute Hoʻoikaika i ka hoʻohui ʻana o ka mālama palliative i nā hoʻolālā lapaʻau mai ka hoʻomaka ʻana. pae nui liʻiliʻi maʻi ʻaʻai māmā. Hiki i ka ʻai kaulike ke kōkua i ka hoʻonui ʻana i ka ikehu, kākoʻo i ka ʻōnaehana pale, a mālama i nā hopena ʻaoʻao o ka mālama ʻana. Hiki i ka meaʻai meaʻai i hoʻopaʻa inoa ke hāʻawi i ke alakaʻi ʻana i nā ʻano meaʻai olakino a paipai i nā mea hoʻohui inā pono. pae nui liʻiliʻi maʻi ʻaʻai māmā ʻilihune maʻamau, akā hiki i ka lāʻau lapaʻau ke kōkua i ke kāohi ʻana i ke kanesa, hoʻomaikaʻi i ka maikaʻi o ke ola, a hoʻolōʻihi i ke ola. ʻO nā koho maʻamau me ka hui oncology he mea nui e nānā no ka hoʻi hou ʻana, mālama i nā hopena ʻaoʻao, a hāʻawi i ke kākoʻo mau. ʻO ka Shandong Baofa Cancer Research Institute ua hoʻolaʻa ʻia i ka hoʻomaikaʻi ʻana i ka prognosis a me ka mālama ʻana i nā maʻi. pae nui liʻiliʻi maʻi ʻaʻai māmā hiki ke paʻakikī, ma ke kino a me ka naʻau. He mea nui ka loaʻa ʻana o kahi ʻōnaehana kākoʻo ikaika, me ka ʻohana, nā hoaaloha, a me nā limahana mālama ola. Hiki i nā hui kākoʻo a me nā lawelawe ʻōlelo aʻoaʻo ke hāʻawi i ke kōkua koʻikoʻi i ka hoʻokō ʻana i nā pilikia o ka maʻi maʻi. Hiki i nā lāʻau lapaʻau, nā lāʻau lapaʻau, a me nā loli ola ke kōkua i ka hoʻēmi ʻana i ka ʻeha, ka luhi, ka pōkole o ka hanu, a me nā hōʻailona ʻē aʻe. He mea nui ke kamaʻilio maʻamau me ka hui mālama ola no ka mālama pono ʻana i nā hōʻailona. He mea nui e ʻimi i ke kākoʻo noʻonoʻo mai nā mea aloha, nā hui kākoʻo, a i ʻole nā ​​ʻoihana olakino noʻonoʻo. ʻO ke kamaʻilio ʻana e pili ana i nā manaʻo a me nā hopohopo hiki ke kōkua i ka hōʻemi ʻana i ke kaumaha a me ka hoʻomaikaʻi ʻana i ke olakino holoʻokoʻa. pae nui liʻiliʻi maʻi ʻaʻai māmā ke hoʻomau nei. ʻO nā lāʻau lapaʻau e kū mai ana, e like me nā lāʻau lapaʻau i manaʻo ʻia a me nā immunotherapies hou, hōʻike i ka ʻōlelo hoʻohiki i ka hoʻomaikaʻi ʻana i nā hopena no nā maʻi me ES-SCLC. Pono nā hoʻokolohua lapaʻau no ka holomua ʻana i ka noiʻi maʻi maʻi a me ka lawe ʻana i nā lāʻau lapaʻau hou i nā maʻi. He mea nui e kūkākūkā me kekahi kauka lapaʻau koʻikoʻi no nā pilikia olakino a i ʻole ma mua o ka hoʻoholo ʻana e pili ana i kou olakino a lapaʻau paha.